Skip to content

Bolar Pharmaceuticals Nigeria Limited

bolarpharm2

Bolar is a leading Nigerian pharmaceutical company established in 1984, but started operations in 1986, with a retail pharmacy. Over the years Bolar has represented several multinational companies in marketing and distribution. These include Johnson and Johnson, Astra Zeneca, Pharmacia and Upjohn, Sanofi, and Grunenthal. Bolar is presently focusing on developing own brands based on unique and natural ingredients and products, as well as new molecules which have been shown extensively to provide viable options for disease management and treatment.

 

Bolar is presently focusing on developing own brands based on unique and natural ingredients and products, as well as new molecules which have been shown extensively to provide viable options for disease management and treatment.

Bolar has partnered with local and international organizations to gain access to these unique ingredients and molecules.

 

Over the coming years, Bolar will be introducing products in chronic disease areas where present treatments are unsatisfactory or could be improved upon. These include sickle cell, hepatitis, diabetes, cancer, BHP (Benign Prostatic Hyperplasia), Cardiovascular disease (CVD) and arthritis.

 

Bolar is now organized along the following business lines:

 

  • Bolar Pharmaceuticals: Marketing and distribution of branded and generic pharmaceuticals
  • Bolar Naturals: These will include nutraceuticals, Herbals, Natural formulations, and will be marketed under the trademarks Bolar Naturals, and Natures Treasures
  • Bolar Ventures: Marketing of innovative functional and health ingredients to other companies
  • Bolar Consulting Services: Providing professional services and advise in the areas of regulatory affairs, as well as other specialized areas.